deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02484833

Erbitux MEtastatic Colorectal Cancer Strategy Study

Erbitux MEtastatic Colorectal Cancer Strategy Study (ERMES): A Phase III Randomized Two Arm Study With FOLFIRI + Cetuximab Until Disease Progression Compared to FOLFIRI + Cetuximab for 8 Cycles Followed by Cetuximab Alone Until Disease Progression in First Line Treatment of Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer

Sponsor: Armando Orlandi

Conditions Antineoplastic Agents
Interventions Cetuximab FOLFIRI
Updated 8 times since 2017 Last updated: Mar 29, 2020 Started: Feb 28, 2015 Primary completion: Dec 31, 2019 Completion: Mar 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02484833, this PHASE3 trial focuses on Antineoplastic Agents and remains completed. Sponsored by Armando Orlandi, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotRecruiting~Mar 2019 – ~May 2019 · 2 months · monthly snapshotUnknown Status~May 2019 – ~Apr 2020 · 11 months · monthly snapshotRecruiting~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  5. May 2019 — Apr 2020 [monthly]

    Recruiting PHASE3

    Status: Unknown Status → Recruiting

▶ Show 3 earlier versions

  1. Mar 2019 — May 2019 [monthly]

    Unknown Status PHASE3

    Status: Recruiting → Unknown Status

  2. Jun 2018 — Mar 2019 [monthly]

    Recruiting PHASE3

  3. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

    First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Armando Orlandi
Data source: Catholic University of the Sacred Heart

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations